Are age-based strategies effective in increasing influenza vaccination coverage?: The Spanish experience

Jiménez‐García, Rodrigo; Herńndez-Barrera, Valentín; Rodríguez-Rieiro, Cristina; Andrés, Ana López de; Miguel‐Díez, Javier de; Trujillo, Isabel; Carrasco‐Garrido, Pilar

doi:10.4161/hv.18433

Cited by 13 publications

(4 citation statements)

References 26 publications

(32 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Furthermore, several studies have shown that an agebased vaccination strategy is more effective than one based on diagnosis or clinical characteristics. [43][44][45][46] Our study has several limitations. First of all, the validity of the questions used by the EHS to classify COPD patients' vaccination status has not been evaluated.…”

Section: Discussionmentioning

confidence: 99%

Influenza vaccination coverage and uptake predictors among Spanish adults suffering COPD

Santos-Sancho

Jiménez‐Trujillo

Hernández-Barrera

et al. 2012

Human Vaccines & Immunotherapeutics

Self Cite

View full text Add to dashboard Cite

Abbreviations: chronic obstructive pulmonary disease, COPDThe aim of this study is to compare influenza vaccination coverage among Spaniards aged 40 y or over who suffer from chronic obstructive pulmonary disease (COPD) with those without this illness to identify the factors that influence vaccination uptake among patients with COPD.Data was extracted from the European Health Survey performed in Spain in 2009/10, and analyzed data on 15,355 Spaniards ($ 40 y of age), of whom 1,309 (8.2% 95% CI 7.7-8.7) had COPD was used. We considered the answer (yes/no) to the question about whether or not the interviewed person had been vaccinated against influenza in the previous flu season. We used the answer to this question as the dependent variable. For independent variables, we analyzed social demographic characteristics, health related variables, and the utilization of health care services.Vaccination coverage among patients with COPD is 49.4% (95% CI: 46.3-52.5%) and 21.3% (95% CI: 20.7-21.9) among people without (p , 0.001). The probability of being vaccinated is three times greater for COPD patients (crude OR = 3.0, 95% CI: 2.6-3.5). Among COPD patients the uptake of vaccination increased with age. Other factors associated with an increase in vaccination coverage were: being male, perceiving one's health as fair or poor, not smoking and having seen a doctor during the previous month.The rate of flu vaccination among adult Spaniards with COPD is lower than desired. Urgent strategies for increasing vaccination coverage are necessary for COPD sufferers aged under 65 of age and those with unhealthy lifestyles.

show abstract

Section: Discussionmentioning

confidence: 99%

Influenza vaccination coverage and uptake predictors among Spanish adults suffering COPD

Santos-Sancho

Jiménez‐Trujillo

Hernández-Barrera

et al. 2012

Human Vaccines & Immunotherapeutics

Self Cite

View full text Add to dashboard Cite

show abstract

“…Other studies have reported similar results [ 21 , 22 ]. This association can be because in Spain, influenza vaccine recommendation is universal for all people aged 65 years or over [ 46 , 47 ]. In addition, multivariable adjustment showed that female gender was associated with lower likelihood of being vaccinated among those reporting diabetes.…”

Section: Discussionmentioning

confidence: 99%

“…Healthcare workers should take all available opportunities in their interactions with diabetic patients to provide objective information about the risks of influenza and the benefits of the influenza vaccine. Patient-level interventions that have proved effective among high-risk patients and should be considered include sending postcards, personalized phone calls, emails, home visits and educational interventions for persons with diabetes and their relatives on the risks of influenza and the need for vaccination [ 46 , 48 , 49 , 63 , 64 , 65 , 66 , 67 , 68 , 69 ].…”

Section: Discussionmentioning

confidence: 99%

Low Levels of Influenza Vaccine Uptake among the Diabetic Population in Spain: A Time Trend Study from 2011 to 2020

Zamorano-León

Jiménez‐García

López‐de‐Andrés

et al. 2021

JCM

Self Cite

View full text Add to dashboard Cite

(1) Background: In this work, we aim to describe influenza vaccine uptake among the diabetic population in Spain to assess the time trend from 2011 to 2020 and identify predictors of vaccine uptake among diabetes patients. (2) Methods: We conducted a descriptive cross-sectional study using the European Health Interview Survey for Spain (2014 and 2020) and the Spanish National Health Surveys (2011 and 2017). The independent variables analysed included socio-demographic characteristics, health-related variables and lifestyle variables. We matched each participant with diabetes with a non-diabetic participant based on age, sex, place of residence and year of survey. (3) Results: The overall coverage among diabetic adults was 52.1% compared to 40.6% for matched participants without diabetes (p < 0.01). The vaccine uptake among adults with diabetes was 52.6% in 2011, 54.38% in 2014 and 53.4% in 2017. The adjusted OR of having been vaccinated in 2020, with respect to 2011, was not significant at 0.87 (95% CI: 0.72–1.06). Factors such as being male, higher age, being affected by respiratory disease or cancer and being physically active were identified as positive predictors for influenza vaccination uptake, while smoking was a negative predictor. (4) Conclusions: The influenza vaccine uptake is below desirable levels among the adult diabetic population in Spain and has not improved from 2011 to 2020. More efforts should be made to increase influenza vaccine uptake in this high-risk group, especially for women, those aged 18–64 years, without other high-risk conditions and smokers.

show abstract

“…An ongoing lowering of the threshold age for recommending influenza vaccination, starting from 60 years old, could benefit the increasing coverage rate in chronic patients. A study conducted in Spain [ 42 ] showed that lowering at 60 years old the age of recommendation increased the vaccination coverage in the target population in all age groups. A pharmacoeconomical analysis applied to the Italian scenario [ 43 ] documented that extending the recommendation to 60–64-year olds would also allow to achieve the protection of many subjects with chronic diseases of this age group at no cost.…”

Section: Discussionmentioning

confidence: 99%

Influenza coverage rates in subjects with chronic heart diseases: results obtained in four consecutive immunisation seasons in the Local Health Unit of Ferrara (North Italy)”

et al. 2020

View full text Add to dashboard Cite

Background Seasonal influenza epidemics yearly affects 5–15% of the world’s population, resulting in 3–5 million serious cases and up to 650,000 deaths. According to the 2017–2019 Italian National Immunisation Plan, free immunisation is offered to the categories at increased risk of experience the complications of the infection (over 65 years old subjects, pregnant women and individuals with underlying conditions, including chronic heart diseases). Rising evidence suggests that influenza can trigger adverse cardiovascular events therefore the vaccination is recommended for secondary prevention of cardiovascular diseases. Despite this, the influenza coverage rate in subjects with chronic heart disease is underestimated. Methods The study investigated the coverage rate in four consecutive influenza seasons (from 2011/2012 to 2014/2015) in subjects that benefit from exemption from paying healthcare costs for chronic heart disease living in Local Health Unit (LHU) of Ferrara (Italy), comparing the databases of exemptions and immunisations. Results The levels of influenza vaccine uptake were unstable, reaching the 50.3% in 2011/2012 immunisation season and falling to 42.2% in the following year. Coverage rates increased with increasing age, without achieving the 75% target, neither in over 65 years old subjects. The logistic regression analysis showed that influenza coverage rates were statistically significant different (p < 0.0001, 0.003 only for category of disease in 2011/2012 immunisation season) according to age, district of residence, category of chronic heart disease and length of exemption, but not influenced by gender. Conclusions The recommendation of influenza immunisation was weakly followed in individuals with chronic heart diseases. A collaboration between cardiologists, GPs, scientific societies and patient associations could successfully support influenza vaccine uptake.

show abstract

Are age-based strategies effective in increasing influenza vaccination coverage?: The Spanish experience

Cited by 13 publications

References 26 publications

Influenza vaccination coverage and uptake predictors among Spanish adults suffering COPD

Influenza vaccination coverage and uptake predictors among Spanish adults suffering COPD

Low Levels of Influenza Vaccine Uptake among the Diabetic Population in Spain: A Time Trend Study from 2011 to 2020

Influenza coverage rates in subjects with chronic heart diseases: results obtained in four consecutive immunisation seasons in the Local Health Unit of Ferrara (North Italy)”

Contact Info

Product

Resources

About